The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Single center experience of IDH inhibitors in high-grade gliomas.
 
Catherine R. Garcia
No Relationships to Disclose
 
Kaitlin N. Highsmith
No Relationships to Disclose
 
Stephanie Knight
No Relationships to Disclose
 
Vinay K. Puduvalli
Stock and Other Ownership Interests - Gilead Sciences
Honoraria - Bayer; Guidepoint Inc; InSightec; Novocure; Orbus Therapeutics; SERVIER; Tango Therapeutics; Telix Pharmaceuticals
Consulting or Advisory Role - Bayer; Guidepoint Inc; InSightec; Newave Pharmaceutical (I); Novocure; Orbus Therapeutics; SERVIER; Tango Therapeutics; Telix Pharmaceuticals
Research Funding - Bexion; InSightec; Karyopharm Therapeutics; Kazia Therapeutics; Merck; Radiomedix; Samus Therapeutics; SERVIER
 
Carlos Kamiya-Matsuoka
No Relationships to Disclose